mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |